Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders. [PDF]
Cho YK, Jung CH.
europepmc +1 more source
Mitochondrial Adaptations in Skeletal Muscle Following Incretin-Based Therapies: In Vitro. [PDF]
Old V +6 more
europepmc +1 more source
Edible Marine Red Alga <i>Gracilaria coronopifolia</i> as a Potential Functional Ingredient: Chemical Profiling and Metabolic Effects in Diet-Induced Obese Rats. [PDF]
Bahtiar A +4 more
europepmc +1 more source
Bridging Pancreatic Amyloidosis and Neurodegeneration: The Emerging Role of Amylin in Diabetic Dementia. [PDF]
Shome G +5 more
europepmc +1 more source
The Obesity Drug Revolution: New Frontiers in Pharmacotherapy. [PDF]
Manoria PC.
europepmc +1 more source
Unraveling α-synuclein and amylin co-aggregation: pathological insights and biomarker development for Parkinson's disease. [PDF]
Zhou Y +18 more
europepmc +1 more source
Disease-disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes. [PDF]
Lin Y +8 more
europepmc +1 more source
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity. [PDF]
Volčanšek Š +4 more
europepmc +1 more source
Comment on Van Der Meer et al. Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study. Diabetes Care 2026;49:658-663. [PDF]
Brown SM +3 more
europepmc +1 more source

